Risk for recurrence increased with surgical delay beyond 12 weeks; overall survival improved with surgery within 12 weeks
Effect of COVID-19 on Breast Cancer Treatment Examined
More patients with estrogen receptor-positive, HER2-negative breast cancer treated with neoadjuvant endocrine therapy due to COVID-19
COVID-19 Infection May Up Mortality in Surgical Patients
Authors recommend postponing surgery for patients with positive preoperative COVID-19 test result
Mortality Up With Surgery Within Six Weeks of SARS-CoV-2 Infection
When possible, delay of at least seven weeks after SARS-CoV-2 diagnosis should be sought; however, mortality rates higher for those with ongoing symptoms
Frequency of Urgent Vitreoretinal Surgery Down During Pandemic
Decreases seen in intravitreal injections, lasers and cryotherapy, retinal detachment repairs, other vitrectomies
Adult Cardiac Surgery Down, Outcomes Worse During Pandemic
Nationally, surgery volume dropped 53 percent, with larger declines in areas harder hit by COVID-19
Head and Neck Cancer Surgery Seems Safe During COVID-19
Links seen for severe pulmonary complications in COVID-19-positive patients with advanced tumor stage, critical care admission
Routine COVID-19 Testing Improves Safety of Elective Surgery
Benefits of nasal swab testing seen in high-transmission areas and before major surgery
COVID-19-Free Surgical Pathways May Aid Cancer Surgery Outcomes
Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways
Bedside Tracheotomy Feasible for Critically Ill COVID-19 Patients
No infection identified among surgeons following procedure; postoperative complications rarely seen